Document:

EX-10.2

 Exhibit 10.2 

REGISTRATION RIGHTS AGREEMENT 

This REGISTRATION RIGHTS AGREEMENT (this “Agreement”) is made and entered into as of December 20, 2019 by and among
Savara Inc., a Delaware corporation (the “Company”), and the “Investors” named in that certain Securities Purchase Agreement by and among the Company and the Investors, dated as of December 20, 2019 (the
“Purchase Agreement”). Capitalized terms used herein have the respective meanings ascribed thereto in the Purchase Agreement unless otherwise defined herein. 

The parties hereby agree as follows: 

1.    Definitions. 

As used in this Agreement, the following terms shall have the following meanings: 

“Agreement” has the meaning set forth in the first paragraph. 

“Allowed Delay” has the meaning set forth in Section 2(c)(ii). 

“Blackout Period” has the meaning set forth in Section 2(d)(ii). 

“Company” has the meaning set forth in the first paragraph. 

“Cut Back Shares” has the meaning set forth in Section 2(e). 

“Effectiveness Period” has the meaning set forth in Section 3(a). 

“Filing Deadline” has the meaning set forth in Section 2(a)(i). 

“Investors” means the Investors identified in the Purchase Agreement and any Affiliate or permitted transferee of any
Investor who is a subsequent holder of Registrable Securities. 
 “Liquidated Damages” has the meaning set forth in
Section 2(d)(ii). 
 “Maintenance Failure” has the meaning set forth in Section 2(d)(ii). 

“Maintenance Liquidated Damages” has the meaning set forth in Section 2(d)(ii). 

“Prospectus” means (i) the prospectus included in any Registration Statement, as amended or supplemented by any
prospectus supplement, with respect to the terms of the offering of any portion of the Registrable Securities covered by such Registration Statement and by all other amendments and supplements to the prospectus, including post-effective amendments
and all material incorporated by reference in such prospectus, and (ii) any “free writing prospectus” as defined in Rule 405 under the 1933 Act. 

“Purchase Agreement” has the meaning set forth in the first paragraph. 

“Qualification Date” has the meaning set forth in Section 2(a)(ii). 

“Qualification Deadline” has the meaning set forth in Section 2(a)(ii). 

  
 1 

 “Register,” “registered” and
“registration” refer to a registration made by preparing and filing a Registration Statement or similar document in compliance with the 1933 Act, and the declaration or ordering of effectiveness of such Registration Statement or
document. 
 “Registrable Securities” means (i) the Shares, (ii) the Warrant Shares and (iii) any other
securities issued or issuable with respect to or in exchange for Shares or Warrant Shares, whether by merger, charter amendment or otherwise; provided, that a security shall cease to be a Registrable Security upon (A) sale pursuant to a
Registration Statement or Rule 144 under the 1933 Act, or (B) such security becoming eligible for sale without restriction by the Investor holding such security pursuant to Rule 144, including without any manner of sale or volume
limitations, and without the requirement to be in compliance with Rule 144(c)(1) (or any successor thereto) promulgated under the 1933 Act. 

“Registration Liquidated Damages” has the meaning set forth in Section 2(d)(i). 

“Registration Statement” means any registration statement of the Company under the 1933 Act that covers the resale of any of
the Registrable Securities pursuant to the provisions of this Agreement, amendments and supplements to such Registration Statement, including post-effective amendments, all exhibits and all material incorporated by reference in such Registration
Statement. 
 “Required Investors” means the Investors holding a majority of the Registrable Securities outstanding from
time to time. 
 “Restriction Termination Date” has the meaning set forth in Section 2(e). 

“SEC” means the U.S. Securities and Exchange Commission. 

“SEC Restrictions” has the meaning set forth in Section 2(e). 

“Shelf Registration Statement” has the meaning set forth in Section 2(a)(ii). 

2.    Registration. 

(a)    Registration Statements. 

(i)    No later than one hundred twenty (120) days after the Closing Date (the “Filing Deadline”),
the Company shall prepare and file with the SEC one Registration Statement covering the resale of all of the Registrable Securities. Subject to any SEC comments, such Registration Statement shall include the plan of distribution attached hereto
as Exhibit A; provided, however, that no Investor shall be named as an “underwriter” in such Registration Statement without the Investor’s prior written consent. Such Registration Statement also shall cover, to the extent
allowable under the 1933 Act and the rules promulgated thereunder (including Rule 416), such indeterminate number of additional shares of Common Stock resulting from stock splits, stock dividends or similar transactions with respect to the
Registrable Securities. Such Registration Statement (and each amendment or supplement thereto, and each request for acceleration of effectiveness thereof) shall be provided in accordance with Section 3(c) to the Investors prior to its filing or
other submission. 
 (ii)    The Registration Statement referred to in Section 2(a)(i) shall be on Form S-3. In the event that Form S-3 is not available for the registration of the resale of Registrable Securities hereunder, the Company shall (i) register the
resale of the Registrable Securities on such other form as is available to the Company and (ii) so long as Registrable Securities remain outstanding, 

  
 2 

 
promptly following the date (the “Qualification Date”) upon which the Company becomes eligible to use a registration statement on Form S-3
to register the Registrable Securities for resale, but in no event more than sixty (60) days after the Qualification Date (the “Qualification Deadline”), file a registration statement on Form
S-3 covering the Registrable Securities (or a post-effective amendment on Form S-3 to a registration statement on
Form S-1) (a “Shelf Registration Statement”) and use commercially reasonable efforts to cause such Shelf Registration Statement to be declared effective as promptly as practicable
thereafter; provided that the Company shall maintain the effectiveness of the Registration Statement then in effect until such time as a Shelf Registration Statement covering the Registrable Securities has been declared effective by the SEC. 

(b)    Expenses. The Company will pay all expenses associated with each Registration Statement, including filing
and printing fees, the Company’s counsel and accounting fees and expenses, costs associated with clearing the Registrable Securities for sale under applicable state securities laws and listing fees, but excluding discounts, commissions, fees of
underwriters, selling brokers, dealer managers or similar securities industry professionals with respect to the Registrable Securities being sold. 

(c)    Effectiveness. 

(i)    The Company shall use commercially reasonable efforts to have each Registration Statement declared effective as
soon as practicable after such Registration Statement has been filed with the SEC. By 5:30 p.m. (Eastern time) on the second Business Day following the date on which the Registration Statement is declared effective by the SEC, the Company shall file
with the SEC, in accordance with Rule 424 under the 1933 Act, the final prospectus to be used in connection with sales pursuant to such Registration Statement. The Company shall notify the Investors by facsimile
or e-mail as promptly as practicable after any Registration Statement is declared effective and shall simultaneously provide the Investors with copies of any related Prospectus to be used in
connection with the sale or other disposition of the securities covered thereby. 
 (ii)    For not more than sixty
(60) consecutive days or for a total of not more than one hundred twenty (120) days in any twelve (12) month period, the Company may suspend the use of any Prospectus included in any Registration Statement contemplated by this Section
in the event that the Company determines in good faith that such suspension is necessary to (A) delay the disclosure of material nonpublic information concerning the Company, the disclosure of which at the time is not, in the good faith opinion
of the Company, in the best interests of the Company or (B) amend or supplement the affected Registration Statement or the related Prospectus so that such Registration Statement or Prospectus shall not include an untrue statement of a material
fact or omit to state a material fact required to be stated therein or necessary to make the statements therein, in the case of the Prospectus in light of the circumstances under which they were made, not misleading (an “Allowed
Delay”); provided, that the Company shall promptly (a) notify each Investor in writing of the commencement of an Allowed Delay, but shall not (without the prior written consent of an Investor) disclose to such Investor any material
nonpublic information giving rise to an Allowed Delay, (b) advise the Investors in writing to cease all sales under such Registration Statement until the end of the Allowed Delay and (c) use commercially reasonable efforts to terminate an
Allowed Delay as promptly as practicable. 
 (d)    Effect of Failure to File and Obtain and Maintain
Effectiveness of Registration Statement. 
 (i)    If a Registration Statement covering the Registrable Securities
is not filed with the SEC on or prior to the Filing Deadline, the Company will make pro rata payments to each Investor then holding Registrable Securities, as liquidated damages and not as a penalty (the “Registration 

  
 3 

 
Liquidated Damages”), in an amount equal to one percent (1.0%) of the aggregate amount invested by such Investor for the initial day of failure to file such Registration Statement by
the Filing Deadline and for each 30-day period (or pro rata portion thereof with respect to a final period, if any) thereafter during which no such Registration Statement is filed with respect to the
Registrable Securities. Such payments shall be made to each Investor then holding Registrable Securities in cash no later than ten (10) Business Days after the end of the date of the initial failure to file such Registration Statement by the
Filing Deadline and each 30-day period (or portion thereof with respect to a final period, if any) thereafter until such Registration Statement is filed with respect to the Registrable Securities.
Interest shall accrue at the rate of one percent (1.0%) per month on any such liquidated damages payments that shall not be paid by the applicable payment date until such amount is paid in full. 

(ii)    If (A) a Registration Statement covering the Registrable Securities is not declared effective by the SEC
prior to the earlier of (i) ten (10) Business Days after the SEC informs the Company that no review of such Registration Statement will be made or that the SEC has no further comments on such Registration Statement or (B) after a
Registration Statement has been declared effective by the SEC, sales cannot be made pursuant to such Registration Statement for any reason (including, without limitation, by reason of a stop order or the Company’s failure to update such
Registration Statement), but excluding any Allowed Delay or the inability of any Investor to sell the Registrable Securities covered thereby due to market conditions (each of (A) and (B), a “Maintenance Failure”), then the
Company will make pro rata payments to each Investor then holding Registrable Securities, as liquidated damages and not as a penalty (the “Maintenance Liquidated Damages” and together with the Registration Liquidated Damages, the
“Liquidated Damages”), in an amount equal to one percent (1.0%) of the aggregate amount invested by such Investor for the Registrable Securities then held by such Investor for the initial day of a Maintenance Failure and for each 30-day period (or pro rata portion thereof with respect to a final period, if any) thereafter until the Maintenance Failure is cured (each, a “Blackout Period”). The Maintenance Liquidated Damages
shall be paid monthly within ten (10) Business Days of the date of such Maintenance Failure and the end of each 30-day period (or portion thereof with respect to a final period, if any) thereafter
until the Maintenance Failure is cured. Such payments shall be made to each Investor then holding Registrable Securities in cash. Interest shall accrue at the rate of one percent (1%) per month on any such liquidated damages payments that shall not
be paid by the applicable payment date until such amount is paid in full. 
 (iii)    The parties agree that
(1) notwithstanding anything to the contrary herein or in the Purchase Agreement, no Liquidated Damages shall be payable with respect to any period after the expiration of the Effectiveness Period (as defined below) (it being understood that
this sentence shall not relieve the Company of any Liquidated Damages accruing prior to the expiration of the Effectiveness Period), and in no event shall the aggregate amount of Liquidated Damages payable to an Investor exceed, in the aggregate,
six percent (6.0%) of the aggregate purchase price paid by such Investor pursuant to the Purchase Agreement and (2) in no event shall the Company be liable in any thirty (30) day period for Liquidated Damages under this Agreement in excess
of one percent (1.0%) of the aggregate purchase price paid by the Investors pursuant to the Purchase Agreement. 

(iv)    Notwithstanding the foregoing, the Company and the Investors agree that the Company will not be liable for any
liquidated damages under this Section 2(d) with respect to any Registrable Securities prior to their issuance. The Liquidated Damages described in this Section 2(d) shall constitute the Investors’ exclusive monetary remedy for any
failure to meet the Filing Deadline and for any Maintenance Failure, but shall not affect the right of the Investors to seek injunctive relief. 

(e)    Rule 415; Cutback. If at any time the SEC takes the position that the offering of some or
all of the Registrable Securities in a Registration Statement is a primary offering or not eligible to 

  
 4 

 
be made on a delayed or continuous basis under the provisions of Rule 415 under the 1933 Act, or requires any Investor to be named as an “underwriter,” the Company shall use
commercially reasonable efforts to advocate before the SEC its reasonable position that the offering contemplated by such Registration Statement is a valid secondary offering and not an offering “by or on behalf of the issuer” as defined
in Rule 415 (a “Constructive Primary Offering”) and that none of the Investors is an “underwriter.” The Investors shall have the right to review and oversee any registration or matters pursuant to this
Section 2(e), including participation in any meetings or discussions with the SEC regarding the SEC’s position and to comment on any written submission made to the SEC with respect thereto. In the event that, despite the Company’s
commercially reasonable efforts, the SEC does not alter its position, the Company shall (i) remove from such Registration Statement such portion of the Registrable Securities (the “Cut Back Shares”) and/or (ii) agree to
such restrictions and limitations on the registration and resale of the Registrable Securities as the SEC may require to assure the Company’s compliance with the requirements of Rule 415 (collectively, the “SEC
Restrictions”); provided, however, that the Company shall not agree to name any Investor as an “underwriter” in such Registration Statement without the prior written consent of such Investor.
Any cut-back imposed on the Investors pursuant to this Section 2(e) shall be allocated among the Investors on a pro rata basis and shall be applied first to any of the Registrable Securities of
such Investor as such Investor shall designate, unless the SEC Restrictions otherwise require or provide or the Investors otherwise agree. The parties agree that the Company’s delay or failure to have a Registration Statement declared effective
due to the SEC taking the position that the offering is a Constructive Primary Offering shall not be a breach of any provision of this Agreement. From and after such date as the Company is able to effect the registration of such Cut Back Shares in
accordance with any SEC Restrictions applicable to such Cut Back Shares (such date, the “Restriction Termination Date”), all of the provisions of this Section 2 (including the Company’s obligations with respect to the
filing of a Registration Statement and its obligations to use commercially reasonable efforts to have such Registration Statement declared effective within the time periods set forth herein and the liquidated damages provisions relating thereto)
shall again be applicable to such Cut Back Shares; provided, however, that the Filing Deadline and/or the Qualification Deadline, as applicable, for such Registration Statement including such Cut Back Shares shall be thirty (30) days after such
Restriction Termination Date. 
 3.    Company Obligations. The Company will use commercially reasonable efforts
to effect the registration of the Registrable Securities in accordance with the terms hereof, and pursuant thereto the Company will, as expeditiously as possible: 

(a)    use commercially reasonable efforts to cause such Registration Statement to become effective and to remain
continuously effective for a period that will terminate upon the earlier of (i) the date on which all Registrable Securities covered by such Registration Statement, as amended from time to time, have been sold, and (ii) the date on which
all Shares and Warrant Shares cease to be Registrable Securities (the “Effectiveness Period”); 

(b)    prepare and file with the SEC such amendments and post-effective amendments to such Registration Statement and the
related Prospectus as may be necessary to keep such Registration Statement effective for the Effectiveness Period and to comply with the provisions of the 1933 Act and the 1934 Act with respect to the distribution of all of the Registrable
Securities covered thereby; 
 (c)    provide copies to and permit each Investor to review each Registration Statement
and all amendments and supplements thereto prior to their filing with the SEC and a reasonable opportunity to furnish comments thereon; 

  
 5 

 (d)    furnish to each Investor whose Registrable Securities are
included in any Registration Statement (i) promptly after the same is prepared and filed with the SEC, if requested by the Investor, one (1) copy of any Registration Statement and any amendment thereto, each preliminary prospectus and
Prospectus and each amendment or supplement thereto, and each letter written by or on behalf of the Company to the SEC or the staff of the SEC, and each item of correspondence from the SEC or the staff of the SEC, in each case relating to such
Registration Statement (other than any portion thereof which contains information for which the Company has sought confidential treatment), and (ii) such number of copies of a Prospectus, including a preliminary prospectus, and all amendments
and supplements thereto and such other documents as each Investor may reasonably request in order to facilitate the disposition of the Registrable Securities owned by such Investor that are covered by such Registration Statement; 

(e)    use commercially reasonable efforts to (i) prevent the issuance of any stop order or other suspension of
effectiveness and, (ii) if such order is issued, obtain the withdrawal of any such order at the earliest practical moment; 

(f)    use commercially reasonable efforts to cause all Registrable Securities covered by a Registration Statement to be
listed on each securities exchange, interdealer quotation system or other market on which similar securities issued by the Company are then listed; 

(g)    promptly notify the Investors, at any time prior to the end of the Effectiveness Period, upon discovery that, or
upon the happening of any event as a result of which, the Prospectus includes an untrue statement of a material fact or omits to state any material fact required to be stated therein or necessary to make the statements therein not misleading in
light of the circumstances then existing (provided that such notice shall not, without the prior written consent of an Investor, disclose to such Investor any material nonpublic information regarding the Company), and promptly prepare, file with the
SEC and furnish to such holder a supplement to or an amendment of such Prospectus as may be necessary so that such Prospectus shall not include an untrue statement of a material fact or omit to state a material fact required to be stated therein or
necessary to make the statements therein not misleading in light of the circumstances then existing; 
 (h)    otherwise
use commercially reasonable efforts to comply with all applicable rules and regulations of the SEC under the 1933 Act and the 1934 Act, including, without limitation, Rule 172 under the 1933 Act, file any final Prospectus, including any
supplement or amendment thereof, with the SEC pursuant to Rule 424 under the 1933 Act, promptly inform the Investors in writing if, at any time during the Effectiveness Period, the Company does not satisfy the conditions specified in
Rule 172 and, as a result thereof, the Investors are required to deliver a Prospectus in connection with any disposition of Registrable Securities and take such other actions as may be reasonably necessary to facilitate the registration of the
Registrable Securities hereunder; and make available to its security holders, as soon as reasonably practicable, an earnings statement covering satisfying the provisions of Section 11(a) of the 1933 Act; 

(i)    within two (2) Business Days after a Registration Statement which covers Registrable Securities is ordered
effective by the SEC, the Company shall deliver to the transfer agent for such Registrable Securities (with copies to the Investors whose Registrable Securities are included in such Registration Statement) confirmation that such Registration
Statement has been declared effective by the SEC; 
 (j)    make available upon reasonable notice at reasonable times
and for reasonable periods for inspection by the Investors and by any attorney, accountant or other agent retained by the 

  
 6 

 
Investors, all pertinent financial and other records and pertinent corporate documents and properties of the Company, and cause all of the Company’s officers, directors and employees and the
independent public accountants who have certified its financial statements to make themselves available to discuss the business of the Company and to supply all information reasonably requested by any such person in connection with such Registration
Statement; provided, however, that the Company shall not disclose material nonpublic information to the Investors, or to advisors to or representatives of the Investors, unless prior to disclosure of such information the Company identifies such
information as being material nonpublic information and provides the Investors, such advisors and such representatives with the opportunity to accept or refuse to accept such material nonpublic information for review; and 

(k)    with a view to making available to the Investors the benefits of Rule 144 (or its successor rule) and any
other rule or regulation of the SEC that may at any time permit the Investors to sell shares of Common Stock to the public without registration, the Company covenants and agrees to: (i) make and keep adequate current public information
available, as those terms are understood and defined in Rule 144, until the earlier of (A) six months after such date as all of the Registrable Securities may be sold without restriction by the holders thereof pursuant to Rule 144 or
any other rule of similar effect or (B) such date as all of the Registrable Securities shall have been resold; (ii) file with the SEC in a timely manner all reports and other documents required of the Company under the 1934 Act; and
(iii) furnish to each Investor upon request, as long as such Investor owns any Registrable Securities, (A) a written statement by the Company that it has complied with the reporting requirements of the 1934 Act, (B) a copy of the
Company’s most recent Annual Report on Form 10-K or Quarterly Report on Form 10-Q, and (C) such other information as may be reasonably
requested in order to avail such Investor of any rule or regulation of the SEC that permits the selling of any such Registrable Securities without registration. 

4.    Obligations of the Investors. 

(i)    Notwithstanding any other provision of the Agreement, no Investor may include any of its Registrable Securities in
the Registration Statement pursuant to this Agreement unless such Investor furnishes to the Company a completed questionnaire substantially in the form of Exhibit B (the “Questionnaire”) for use in connection with the
Registration Statement at least five (5) Business Days prior to the anticipated filing date of the Registration Statement if such Investor elects to have any of the Registrable Securities included in such Registration Statement. In addition to
the Questionnaire, each Investor shall furnish such other information as shall be reasonably required to effect the registration of such Registrable Securities, and shall execute such documents in connection with such registration as the Company may
reasonably request. 
 (b)    Each Investor, by its acceptance of the Registrable Securities, agrees to cooperate with
the Company as reasonably requested by the Company in connection with the preparation and filing of a Registration Statement hereunder, unless such Investor has notified the Company in writing of its election to exclude all of its Registrable
Securities from such Registration Statement. 
 (c)    Each Investor agrees that, upon receipt of any notice from the
Company of either (i) the commencement of an Allowed Delay pursuant to Section 2(c)(ii) or (ii) the happening of an event pursuant to Section 3(g) hereof, such Investor will immediately discontinue disposition of Registrable
Securities pursuant to any Registration Statement covering such Registrable Securities, until the Investor is advised by the Company that such dispositions may again be made. 

  
 7 

 (d)    Each Investor covenants and agrees that it will comply with the
prospectus delivery requirements of the 1933 Act as applicable to it or an exemption therefrom in connection with sales of Registrable Securities pursuant to any Registration Statement. 

5.    Indemnification. 

(a)    Indemnification by the Company. The Company will indemnify and hold harmless each Investor and its officers,
directors, members, employees and agents, and each other person, if any, who controls such Investor within the meaning of the 1933 Act, against any losses, claims, damages or liabilities (collectively, “Losses”), joint or several,
to which they may become subject under the 1933 Act or otherwise, insofar as such Losses (or actions in respect thereof) arise out of or are based upon (i) any untrue or alleged untrue statement of any material fact contained in any
Registration Statement, any preliminary Prospectus or final Prospectus, or any amendment or supplement thereof, (ii) any omission or alleged omission of a material fact required to be stated therein or necessary to make the statements in any
preliminary Prospectus or final Prospectus, or any amendment or supplement thereof, in light of the circumstances under which they were made not misleading or (iii) any violation or alleged violation by the Company or any of its subsidiaries of
any federal, state, foreign or common law rule or regulation applicable to the Company or any of its subsidiaries and relating to action or inaction in connection with any such registration, disclosure document or other document or report, except to
the extent that any such Losses arise out of or are based upon (i) an untrue statement or alleged untrue statement or omission or alleged omission so made in conformity with Investor Information, (ii) the use by an Investor of an outdated
or defective Prospectus after the Company has notified such Investor in writing that such Prospectus is outdated or defective; or (iii) an Investor’s failure to send or give a copy of the Prospectus or supplement (as then amended or
supplemented), if required (and not exempted) to the Persons asserting an untrue statement or omission or alleged untrue statement or omission at or prior to the written confirmation of the sale of Registrable Securities. 

(b)    Indemnification by the Investors. Each Investor agrees, severally but not jointly, to indemnify and hold
harmless, to the fullest extent permitted by law, the Company, its directors, officers, employees, stockholders and each person who controls the Company (within the meaning of the 1933 Act) against any Losses resulting from any untrue statement of a
material fact or any omission of a material fact required to be stated in any Registration Statement or Prospectus or preliminary Prospectus or amendment or supplement thereto or necessary to make the statements therein not misleading, to the
extent, but only to the extent that such untrue statement or omission is contained in any information furnished in writing by such Investor, relating to such Investor, to the Company specifically for inclusion in such Registration Statement or
Prospectus or amendment or supplement thereto (“Investor Information”). In no event shall the liability of an Investor be greater in amount than the dollar amount of the proceeds (net of all expense paid by such Investor in
connection with any claim relating to this Section 5 and the amount of any damages such Investor has otherwise been required to pay by reason of such untrue statement or omission) received by such Investor upon the sale of the Registrable
Securities included in such Registration Statement giving rise to such indemnification obligation. 
 (c)    Conduct
of Indemnification Proceedings. Any person entitled to indemnification hereunder shall (i) give prompt written notice to the indemnifying party of any claim with respect to which it seeks indemnification and (ii) permit such
indemnifying party to assume the defense of such claim with counsel reasonably satisfactory to the indemnified party; provided that any person entitled to indemnification hereunder shall have the right to employ separate counsel and to participate
in the defense of such claim, but the fees and expenses of such counsel shall be at the expense of such person unless (a) the indemnifying party has agreed in writing to pay such fees or expenses, (b) the indemnifying party shall have
failed to assume the defense of such claim and employ counsel reasonably satisfactory to 

  
 8 

 
such person or (c) in the reasonable judgment of any such person, based upon written advice of its counsel, a conflict of interest exists between such person and the indemnifying party with
respect to such claims (in which case, if the person notifies the indemnifying party in writing that such person elects to employ separate counsel at the expense of the indemnifying party, the indemnifying party shall not have the right to assume
the defense of such claim on behalf of such person); and provided, further, that the failure of any indemnified party to give written notice as provided herein shall not relieve the indemnifying party of its obligations hereunder, except to the
extent that such failure to give notice shall materially adversely affect the indemnifying party in the defense of any such claim or litigation. It is understood that the indemnifying party shall not, in connection with any proceeding in the same
jurisdiction, be liable for fees or expenses of more than one separate firm of attorneys at any time for all such indemnified parties. No indemnifying party will, except with the consent of the indemnified party, which shall not be unreasonably
withheld or conditioned, consent to entry of any judgment or enter into any settlement that does not include as an unconditional term thereof the giving by the claimant or plaintiff to such indemnified party of a release from all liability in
respect of such claim or litigation. 
 (d)    Contribution. If for any reason the indemnification provided for
in the preceding paragraphs (a) and (b) is unavailable to an indemnified party or insufficient to hold it harmless, other than as expressly specified therein, then the indemnifying party shall contribute to the amount paid or payable by
the indemnified party as a result of such loss, claim, damage or liability in such proportion as is appropriate to reflect the relative fault of the indemnified party and the indemnifying party, as well as any other relevant equitable
considerations. No person guilty of fraudulent misrepresentation within the meaning of Section 11(f) of the 1933 Act shall be entitled to contribution from any person not guilty of such fraudulent misrepresentation. In no event shall the
contribution obligation of an Investor be greater in amount than the dollar amount of the proceeds (net of all expenses paid by such holder in connection with any claim relating to this Section 5 and the amount of any damages such holder has
otherwise been required to pay by reason of such untrue or alleged untrue statement or omission or alleged omission) received by it upon the sale of the Registrable Securities giving rise to such contribution obligation. 

6.    Miscellaneous. 

(a)    Effective Date. This Agreement shall be effective as of the Closing, and if the Closing has not occurred on
or prior to fifth Trading Day following the date of the Purchase Agreement, unless otherwise mutually agreed, then this Agreement shall be null and void. 

(b)    Amendments and Waivers. This Agreement may be amended only by a writing signed by the Company and the
Required Investors. The Company may take any action herein prohibited, or omit to perform any act herein required to be performed by it, only if the Company shall have obtained the written consent to such amendment, action or omission to act of the
Required Investors. 
 (c)    Notices. All notices and other communications provided for or permitted hereunder
shall be made as set forth in Section 9.4 of the Purchase Agreement. 
 (d)    Assignments and Transfers by
Investors. The provisions of this Agreement shall be binding upon and inure to the benefit of the Investors and their respective successors and assigns. An Investor may transfer or assign, in whole or from time to time in part, to one or more
persons its rights hereunder in connection with the transfer of Registrable Securities by such Investor to such person, provided that such Investor complies with all laws applicable thereto, and the provisions of the Purchase Agreement, and provides
written notice of assignment to the Company promptly after such assignment is effected, and such person agrees in writing to be bound by all of the provisions contained herein. 

  
 9 

 (e)    Assignments and Transfers by the Company. This Agreement
may not be assigned by the Company (whether by operation of law or otherwise) without the prior written consent of the Required Investors, provided, however, that in the event that the Company is a party to a merger, consolidation, share exchange or
similar business combination transaction in which the Common Stock is converted into the equity securities of another Person, from and after the effective time of such transaction, such Person shall, by virtue of such transaction, be deemed to have
assumed the obligations of the Company hereunder, the term “Company” shall be deemed to refer to such Person and the term “Registrable Securities” shall be deemed to include the securities received by the Investors in connection
with such transaction unless such securities are otherwise freely tradable by the Investors after giving effect to such transaction. 

(f)    Benefits of the Agreement. The terms and conditions of this Agreement shall inure to the benefit of and be
binding upon the respective permitted successors and assigns of the parties. Nothing in this Agreement, express or implied, is intended to confer upon any party other than the parties hereto or their respective successors and assigns any rights,
remedies, obligations, or liabilities under or by reason of this Agreement, except as expressly provided in this Agreement. 

(g)    Counterparts. This Agreement may be executed in two or more counterparts, each of which shall be deemed an
original, but all of which together shall constitute one and the same instrument. Counterparts may be delivered via facsimile, electronic mail (including pdf or any electronic signatures complying with the U.S. federal ESIGN Act of 2000, e.g.,
www.docusign.com) or other transmission method and any counterpart so delivered shall be deemed to have been duly and validly delivered and be valid and effective for all purposes. 

(h)    Titles and Subtitles. The titles and subtitles used in this Agreement are used for convenience only and are
not to be considered in construing or interpreting this Agreement. 
 (i)    Severability. Any provision of this
Agreement that is prohibited or unenforceable in any jurisdiction shall, as to such jurisdiction, be ineffective to the extent of such prohibition or unenforceability without invalidating the remaining provisions hereof but shall be interpreted as
if it were written so as to be enforceable to the maximum extent permitted by applicable law, and any such prohibition or unenforceability in any jurisdiction shall not invalidate or render unenforceable such provision in any other jurisdiction. To
the extent permitted by applicable law, the parties hereby waive any provision of law which renders any provisions hereof prohibited or unenforceable in any respect. 

(j)    Further Assurances. The parties shall execute and deliver all such further instruments and documents and
take all such other actions as may reasonably be required to carry out the transactions contemplated hereby and to evidence the fulfillment of the agreements herein contained. 

(k)    Entire Agreement. This Agreement is intended by the parties as a final expression of their agreement and
intended to be a complete and exclusive statement of the agreement and understanding of the parties hereto in respect of the subject matter contained herein. This Agreement supersedes all prior agreements and understandings between the parties with
respect to such subject matter. 
 (l)    Governing Law. This Agreement shall be governed by, and construed in
accordance with, the laws of the State of Delaware. Service of process in connection with any such suit, action or proceeding may be served on each party hereto anywhere in the world by the same methods as are specified for the giving of notices
under this Agreement. 

  
 10 

 (m)    Cumulative Remedies. The remedies provided herein are
cumulative and not exclusive of any remedies provided by law. 
 [remainder of page intentionally left blank] 

  
 11 

 IN WITNESS WHEREOF, the parties have executed this Agreement or caused their duly authorized
officers to execute this Agreement as of the date first above written. 
  

			
	COMPANY:
	
	SAVARA INC.
		
	By:	 	 /s/ Robert Neville

		 	Name: Robert Neville
		 	Title: Chief Executive Officer
	
	INVESTOR:
	
	 Bain Capital Life Sciences Fund II, L.P.

	
	 By: Bain Capital Life Sciences Investors II, LLC

its general partner

	
	 By: Bain Capital Life Sciences Investors, LLC

its manager

		
	By:	 	 /s/ Jeffrey Schwartz

		 	Name: Jeffrey Schwartz
		 	Title: Managing Director
	
	INVESTOR:
	
	 BCIP Life Sciences Associates, LP

	
	By: Boylston Coinvestors, LLC its general partner
		
	By:	 	 /s/ Jeffrey Schwartz

		 	Name: Jeffrey Schwartz
		 	Title: Authorized Signatory
	
	INVESTOR:
	
	EcoR1 Capital Fund, L.P.
		
	By:	 	 /s/ Oleg Nodelman

		 	Name: Oleg Nodelman
		 	Title: Manager, EcoR1 Capital LLC, as GP
	
	INVESTOR:
	
	EcoR1 Capital Fund Qualified, L.P.
		
	By:	 	 /s/ Oleg Nodelman

		 	Name: Oleg Nodelman
		 	Title: Manager, EcoR1 Capital LLC, as GP
	
	INVESTOR:
	
	CVI Investments Inc., By Heights Capital Management its Authorized Agent
		
	By:	 	 /s/ Martin Kobinger

		 	Name: Martin Kobinger
		 	Title:Investment Manager

  
 12 

 
			
	INVESTOR:
	
	Commodore Capital Master LP
		
	By:	 	 /s/ R. Egen Atkinson

		 	Name: R. Egen Atkinson
		 	Title: Authorized Signatory
	
	INVESTOR:
	
	BEMAP Master Fund LTD
		
	By:	 	 /s/ Eric Delbridge

		 	Name: Eric Delbridge
		 	Title: Authorized Signer
	
	INVESTOR:
	
	Sofinnova BioEquities Master Fund Ltd.
		
	By:	 	 /s/ Eric Delbridge

		 	Name: Eric Delbridge
		 	Title: Authorized Signer
	
	INVESTOR:
	
	Crestline Summit Master, SPC on behalf and for the account of Peak SP
		
	By:	 	Crestline Management, L.P., its Investment Manager
		
	By:	 	Crestline Investors, Inc., its General Partner
		
	By:	 	 /s/ John S. Cochran

		 	Name: John S. Cochran
		 	Title: Vice President

  
 13 

 
			
	INVESTOR:
	
	LOGOS GLOBAL MASTER FUND, L.P.
	By: Logos GP, LLC
	Its General Partner
		
	By:	 	 /s/ Arsani William

		 	Name: Arsani William
		 	Title: Manager
	
	INVESTORS:
	
	 Farallon Capital Partners, L.P.

Farallon Capital Institutional Partners, L.P.
 Four Crossings
Institutional Partners V, L.P.
 Farallon Capital Institutional Partners II, L.P.

Farallon Capital Offshore Investors II, L.P.
 Farallon Capital F5
Master I, L.P.
 Farallon Capital (AM) Investors, L.P.
 Farallon
Capital Institutional Partners III, L.P.

		
	By:	 	 /s/ Philip D. Dreyfuss

		 	Name: Philip D. Dreyfuss
		 	Title: Managing Member, Farallon Capital Management, L.L.C., as agent and investment manager on behalf of each respective entity listed above (each such entity severally and not jointly an Investor).

  
 14 

 EXHIBIT A 

Plan of Distribution 
 The
selling stockholders, which as used herein includes donees, pledgees, transferees or other successors-in-interest selling shares of common stock or interests
in shares of common stock received after the date of this prospectus from a selling stockholder as a gift, pledge, partnership distribution or other transfer, may, from time to time, sell, transfer or otherwise dispose of any or all of their shares
of common stock or interests in shares of common stock on any stock exchange, market or trading facility on which the shares are traded or in private transactions. These dispositions may be at fixed prices, at prevailing market prices at the time of
sale, at prices related to the prevailing market price, at varying prices determined at the time of sale, or at negotiated prices. 
 The
selling stockholders may use any one or more of the following methods when disposing of shares or interests therein: 
  

	 	•	 	 ordinary brokerage transactions and transactions in which the broker-dealer solicits purchasers;

  

	 	•	 	 block trades in which the broker-dealer will attempt to sell the shares as agent, but may position and resell a
portion of the block as principal to facilitate the transaction; 

  

	 	•	 	 purchases by a broker-dealer as principal and resale by the broker-dealer for its account; 

 

	 	•	 	 an exchange distribution in accordance with the rules of the applicable exchange; 

 

	 	•	 	 privately negotiated transactions; 

 

	 	•	 	 short sales effected after the date the registration statement of which this prospectus is a part is declared
effective by the SEC; 

  

	 	•	 	 through the writing or settlement of options or other hedging transactions, whether through an options exchange
or otherwise; 

  

	 	•	 	 broker-dealers may agree with the selling stockholders to sell a specified number of such shares at a stipulated
price per share; 

  

	 	•	 	 a combination of any such methods of sale; and 

 

	 	•	 	 any other method permitted by applicable law. 

The selling stockholders may, from time to time, pledge or grant a security interest in some or all of the shares of common stock owned by
them and, if they default in the performance of their secured obligations, the pledgees or secured parties may offer and sell the shares of common stock, from time to time, under this prospectus, or under an amendment to this prospectus under
Rule 424(b)(3) or other applicable provision of the Securities Act of 1933, as amended (the “Securities Act”), amending the list of selling stockholders to include the pledgee, transferee or other successors in interest as
selling stockholders under this prospectus. The selling stockholders also may transfer the shares of common stock in other circumstances, in which case the transferees, pledgees or other successors in interest will be the selling beneficial owners
for purposes of this prospectus. 
 In connection with the sale of our common stock or interests therein, the selling stockholders may enter
into hedging transactions with broker-dealers or other financial institutions, which may in turn engage in short sales of the common stock in the course of hedging the positions they assume. The selling stockholders may also sell shares of our
common stock short and deliver these securities to close out their short positions, or loan or pledge the common stock to broker-dealers that in turn may sell these securities. The selling stockholders may also enter into option or other
transactions with broker-dealers or 

  
 15 

 
other financial institutions or the creation of one or more derivative securities which require the delivery to such broker-dealer or other financial institution of shares offered by this
prospectus, which shares such broker-dealer or other financial institution may resell pursuant to this prospectus (as supplemented or amended to reflect such transaction). 

The aggregate proceeds to the selling stockholders from the sale of the common stock offered by them will be the purchase price of the common
stock less discounts or commissions, if any. Each of the selling stockholders reserves the right to accept and, together with their agents from time to time, to reject, in whole or in part, any proposed purchase of common stock to be made directly
or through agents. We will not receive any of the proceeds from this offering. Upon any exercise of the warrants by payment of cash, however, we will receive the exercise price of the warrants. 

The selling stockholders also may resell all or a portion of the shares in open market transactions in reliance upon Rule 144 under the
Securities Act of 1933, provided that they meet the criteria and conform to the requirements of that rule. 
 The selling stockholders and
any underwriters, broker-dealers or agents that participate in the sale of the common stock or interests therein may be “underwriters” within the meaning of Section 2(11) of the Securities Act. Any discounts, commissions, concessions
or profit they earn on any resale of the shares may be underwriting discounts and commissions under the Securities Act. Selling stockholders who are “underwriters” within the meaning of Section 2(11) of the Securities Act will be
subject to the prospectus delivery requirements of the Securities Act. 
 To the extent required, the shares of our common stock to be sold,
the names of the selling stockholders, the respective purchase prices and public offering prices, the names of any agents, dealer or underwriter, and any applicable commissions or discounts with respect to a particular offer will be set forth in an
accompanying prospectus supplement or, if appropriate, a post-effective amendment to the registration statement that includes this prospectus. 

In order to comply with the securities laws of some states, if applicable, the common stock may be sold in these jurisdictions only through
registered or licensed brokers or dealers. In addition, in some states the common stock may not be sold unless it has been registered or qualified for sale or an exemption from registration or qualification requirements is available and is complied
with. 
 We have advised the selling stockholders that the anti-manipulation rules of Regulation M under the Securities Exchange Act of
1934, as amended, may apply to sales of shares in the market and to the activities of the selling stockholders and their affiliates. In addition, to the extent applicable, we will make copies of this prospectus (as it may be supplemented or amended
from time to time) available to the selling stockholders for the purpose of satisfying the prospectus delivery requirements of the Securities Act. The selling stockholders may indemnify any broker-dealer that participates in transactions involving
the sale of the shares against certain liabilities, including liabilities arising under the Securities Act. 
 We have agreed to indemnify
the selling stockholders against liabilities, including liabilities under the Securities Act and state securities laws, relating to the registration of the shares offered by this prospectus. 

We have agreed with the selling stockholders to use commercially reasonable efforts to cause the registration statement of which this
prospectus constitutes a part effective and to remain continuously effective until the earlier of (1) such time as all of the shares covered by this prospectus have been disposed of pursuant to and in accordance with such registration statement
or (2) the date on which all of the shares may be sold without restriction pursuant to Rule 144 of the Securities Act. 

  
 16 

 EXHIBIT B 

FORM OF 
 SELLING
SECURITYHOLDER QUESTIONNAIRE 
 Reference is made to that certain registration rights agreement (the “Registration Rights
Agreement”), dated as of December 20, 2019, by and among Savara Inc. (the “Company”), and [______________]. Capitalized terms used and not defined herein shall have the meanings given to such terms in the
Registration Rights Agreement. 
 The undersigned Holder (the “Selling Securityholder”) of the Registrable Securities is providing
this Selling Securityholder Questionnaire pursuant to Section 4(a) of the Registration Rights Agreement. The Selling Securityholder, by signing and returning this Selling Securityholder Questionnaire, understands that it will be bound by the
terms and conditions of this Selling Securityholder Questionnaire and the Registration Rights Agreement. The Selling Securityholder hereby acknowledges its indemnity obligations pursuant to Section 5(b) of the Registration Rights Agreement.

 The Selling Securityholder provides the following information to the Company and represents and warrants that such information is accurate and complete:

  

					
	(1)	 	(a)	  	Full Legal Name of Selling Securityholder:
		 		  	                                     
                                         
  
			
		 	(b)	  	Full Legal Name of Registered Holder (if not the same as (a) above) through which Registrable Securities listed in (3) below are held:
		 		  	                                     
                                         
  
			
		 	(c)	  	Full Legal Name of DTC Participant (if applicable and if not the same as (b) above) through which Registrable Securities listed in (3) below are held:
		 		  	                                     
                                         
  
		 		  	
	(2)	 	Address for Notices to Selling Securityholder:
		 		  	                                     
                                         
  
		 		  	                                     
                                         
  
	Telephone (including area
code):                                        
                        
	Fax (including area
code):                                        
                                
	Contact Person:
                                         
                                   
		
	(3)	 	Beneficial Ownership of Registrable Securities:
		 	                                   
                                         
                                
		
	(a)	 	Type and Principal Amount/Number of Registrable Securities beneficially owned:
		 	                                   
                                         
                                
		
	(b)	 	CUSIP No(s). of such Registrable Securities beneficially owned:
		 	                                   
                                         
                                
		
	(4)	 	Beneficial Ownership of Other Securities of the Company Owned by the Selling Securityholder:
		
		 	Except as set forth below in this Item (4), the Selling Securityholder is not the beneficial or registered owner of any securities of the Company other than the Registrable Securities listed above in Item
(3).
			
		 	(a)	  	Type and Amount of Other Securities beneficially owned by the Selling Securityholder:
		
		 	                                   
                                         
                                

  
 17 

			
	(b)	  	CUSIP No(s). of such Other Securities beneficially owned:
		
	(5)	  	Relationship with the Company:
		
		  	Except as set forth below, neither the Selling Securityholder nor any of its affiliates, officers, directors or principal equity holders (5% or more) has held any position or office or has had any other material relationship
with the Company (or its predecessors or affiliates) during the past three years.
	
	State any exceptions here:
		
	(6)	  	Is the Selling Securityholder a registered broker-dealer?
	Yes	  	☐
	No	  	☐
	
	If “Yes”, please answer subsection (a) and subsection (b):

  

					
		 	(a) Did the Selling Securityholder acquire the Registrable Securities as compensation for underwriting/broker-dealer activities to the Company?
		 	 Yes   ☐

		 	 No   ☐

		
		 	(b) If you answered “No” to question 6(a), please explain your reason for acquiring the Registrable Securities:
		 	                                    
                                         
               
		 	                                    
                                         
               

  

			
	(7)	  	Is the Selling Securityholder an affiliate of a registered broker-dealer?
	Yes	  	☐
	No	  	☐
	
	 If “Yes”, please identify the registered broker-dealer(s), describe the nature of the
affiliation(s) and answer subsection (a) and subsection (b):

					
	                                    
                                         
               
	                                    
                                         
               
		
		 	(a) Did the Selling Securityholder purchase the Registrable Securities in the ordinary course of business (if no, please explain)?
		 	 Yes   ☐

		 	 No   ☐

 Explain: 

					
	                                    
                                         
               
	                                    
                                         
               
		
		 	(b) Did the Selling Securityholder have an agreement or understanding, directly or indirectly, with any person to distribute the Registrable Securities at the same time the Registrable Securities were originally
purchased (if yes, please explain)?
		 	 Yes   ☐

		 	 No   ☐

  

			
	Explain:	  	
		
	(8)	  	Is the Selling Securityholder a non-public entity?
	Yes	  	☐
	No	  	☐

  
 18 

 If “Yes”, please answer subsection (a): 

(a) Identify the natural person or persons that have voting or investment control over the Registrable Securities that the non-public entity owns: 
 (9)    Plan of Distribution: 

The Selling Securityholder (including its donees and pledgees) intends to distribute the Registrable Securities listed above in Item (3) pursuant to the
Registration Statement in accordance with the Plan of Distribution attached as Exhibit A to the Registration Rights Agreement. 
 The Selling Securityholder
acknowledges that it understands its obligations to comply with the provisions of the Securities Exchange Act of 1934, as amended, and the rules thereunder relating to stock manipulation, particularly Regulation M thereunder (or any successor rules
or regulations), in connection with any offering of Registrable Securities pursuant to the Shelf Registration Agreement. The Selling Securityholder agrees that neither it nor any person acting on its behalf will engage in any transaction in
violation of such provisions. 
 Pursuant to the Registration Rights Agreement, the Company has agreed under certain circumstances to indemnify the Selling
Securityholder against certain liabilities. 
 In the event the Selling Securityholder transfers all or any portion of the Registrable Securities listed in
Item (3) above after the date on which such information is provided to the Company other than pursuant to the Registration Statement, the Selling Securityholder agrees to notify the transferee(s) at the time of the transfer of its rights and
obligations under this Selling Securityholder Questionnaire and the Registration Rights Agreement. 
 In accordance with the Selling Securityholder’s
obligation under the Registration Rights Agreement to provide such information as may be required by law or by the staff of the SEC for inclusion in the Registration Statement, the Selling Securityholder agrees to promptly notify the Company of any
inaccuracies or changes in the information provided herein that may occur subsequent to the date hereof at anytime while the Registration Statement remains effective. All notices to the Selling Securityholder pursuant to the Registration Rights
Agreement shall be made in writing, by hand-delivery, first-class mail, or air courier guaranteeing overnight delivery to the address set forth below. 
 By
signing below, the Selling Securityholder consents to the disclosure of the information contained herein in its answers to Items (1) through (9) above and the inclusion of such information in the Registration Statement and the related
Prospectus. The undersigned understands that such information will be relied upon by the Company in connection with the preparation or amendment of the Registration Statement and the related Prospectus. 

By signing below, the undersigned agrees that if the Company notifies the undersigned that the Registration Statement is not available pursuant to the terms
of the Registration Rights Agreement, the undersigned will suspend use of the Prospectus until notice from the Company that the Prospectus is again available. 

Once this Selling Securityholder Questionnaire is executed by the undersigned and received by the Company, the terms of this Selling Securityholder
Questionnaire, and the representations, warranties and agreements contained herein, shall be binding on, shall inure to the benefit of and shall be enforceable by the respective successors, heirs, personal representatives, and assigns of the Company
and the undersigned with respect to the Registrable Securities beneficially owned by the undersigned and listed in Item (3) above. This Selling Securityholder Questionnaire shall be governed by and construed in accordance with the laws of the
State of New York without regard to choice of laws or conflicts of laws provisions thereof that would require the application of the laws of any other jurisdiction. 

  
 19 

 IN WITNESS WHEREOF, the undersigned, by authority duly given, has caused this Selling
Securityholder Questionnaire to be executed and delivered either in person or by its duly authorized agent. 

Dated:                         
                                  

 

	
	  

Beneficial Owner

	 By: /s/

	
Name:                  
                                         
                            

	
Title:                  
                                         
                              

 PLEASE RETURN THE COMPLETED AND EXECUTED 

SELLING SECURITYHOLDER QUESTIONNAIRE TO THE COMPANY AT: 

  
 20Exhibit
10.1

 

 

This
LOAN AGREEMENT (“Agreement”), made as of December 18, 2019, by and between Xantis S.A.
a company incorporated under the laws of Luxembourg that is the legally appointed fund management company of Keyholder Three
Securitisation Fund (to be renamed Aegeus Securitisation Fund), having its registered office located in 75 Parc d'Activités,
L-8308 Capellen, Grand Duchy of Luxembourg and Argentum 47, Inc., a corporation organized under the laws of the State of
Nevada, United States of America, whose principal place of business is currently 34 Augustine ́s Gate, Hedon, HU12 8EX, Hull,
United Kingdom.

 

RECITALS:

 

	 	A.	The
    Lender is Keyholder Three Securitisation Fund (to be renamed Aegeus Securitisation Fund).
	 	B.	The
    Borrower, Argentum 47, Inc., is a corporate consulting business that desires to obtain funding from the Lender, on the terms
    and conditions set forth below.
	 	C.	The
    Borrower ́s common shares are currently traded on the US NASDAQ OTC, trading symbol ARGQ and International Securities
    Identification Number (ISIN) US 04017D1046.

 

NOW,
THEREFORE, in consideration of the mutual covenants contained herein, the parties hereto agree as follows:

 

1.
Financing Commitment.

 

The
Lender agrees to provide to Borrower up to £500,000 GBP in loans (equivalent to approximately U.S.$658,200 at the date of
this agreement), in two or more tranches at the discretion of the lender commencing with a first tranche amounting to £250,000
GBP (equivalent to approximately U.S.$329,100 at the date of this agreement) that shall be wired to the escrow account of the
Company ́s U.S. Attorney, Mr. David E. Wise, Esq. today. Once the contracts are fully executed, the amount will be released
from escrow to the Borrower.

 

2.
Term.

 

The
Parties agree that the initial term of this loan shall be Two (2) years commencing from the date of execution of this agreement.

 

The
Parties agreed that the Lender will have the option to prolong this Two (2) year term for subsequent 12-month periods and under
the same terms as the initial agreement. If the term is prolonged by 12-months or more, then the option to convert to equity will
also be prolonged by the same number of months.

 

The
Parties agree that if the Lender opts to prolong the term of this agreement, Argentum 47, Inc. will be informed of this decision
in writing 30-days before the initial agreed terms ends.

 

3.
Interest.

 

The
Parties agree to an annual interest rate of 6% of the borrowed amount based on the principal amounts effectively received. Interest
shall be payable on an annual basis.

 

4.
Receivable Assignment Agreement.

 

The
Parties will simultaneously enter into a Receivable Assignment Agreement whereby an amount of the receivables from Argentum and/or
the next Independent Financial Advisory firm acquired will be securitised to Keyholder Three Securitisation Fund (to be
renamed Aegeus Securitisation Fund).

 

    	 

    	 

    

 

5.
Conversion Rights.

 

At
the sole option of Lender or its fund management company, Xantis S.A., this loan can convert into common shares of Company, from
time to time, at least two (2) years and One (1) day from the date of execution of the agreement.

 

If
the Lender or its fund management company, Xantis S.A., opt to convert the loan to common shares then conversion price per share
agreed shall be the closing market price two (2) trading days prior to the Conversion date.

 

6.
Repayment.

 

Argentum
47, Inc. shall have the option to repay all or part of the loan amount at any time on or before the agreed term without penalty.

 

7.
Fees.

 

No
fees for the setup of the funding structure shall be borne by Argentum 47, Inc.

 

8.
Notices.

 

Any
notice, request, direction or acknowledgement required or permitted to be given hereunder shall be in writing and shall be properly
given by personal delivery or by sending same by any form of telecommunication device to the party for whom it is intended to
the respective address set forth below or to such other address as either party may from time to time specify by notice given
in accordance herewith. Except as expressly otherwise provided in this Agreement, any notice, if delivered as aforesaid, shall
be effective on the date of delivery; and, if sent in the form of a telecommunication device, shall be effective on the business
day following the day on which it was sent. Until changed, the addresses for notice of the parties shall be:

 

If
to Borrower:

 

Attention:
Mr. Enzo Taddei / Mr. Peter Smith

 

34
St. Augustine’s Gate,

Hedon,

HU12
8EX, Hull,

United
Kingdom.

 

If
to Lender:

 

Attention:
The Board of Directors of Xantis S.A.

 

75
Parc d’Activités,

L-8308
Capellen,

Grand-Duchy
of Luxembourg.

 

9.
Amendment; Breach and Waiver.

 

This
Agreement may not be amended or modified in any manner, except by an instrument in writing duly executed by both parties hereto.
The failure of either party hereto to enforce at any time any of the provisions of this Agreement shall in no way be construed
to constitute a waiver of any such provision or any other provision, or of the right of such party thereafter to enforce each
and every such provision or other provision in the event of a subsequent breach of this Agreement.

 

10.
Agreement Binding Upon Successors.

 

This
Agreement shall inure to the benefit of, and shall be binding upon, the Parties hereto, their successors and assigns.

 

11.
Choice of Law and Forum. 

 

This Agreement shall
be governed by and construed in accordance with the laws of Grand Duchy of Luxembourg, exclusive of its choice-of-law principles.
Each party hereby submits to the jurisdiction of the civil courts of Grand Duchy of Luxembourg. In any action or proceeding arising
out of or relating to this Agreement pursuant hereto, each party hereto hereby irrevocably waives the defense of improper
venue or inconvenient forum for the maintenance of any such action or proceeding to the fullest extent permitted by law.

 

12.
Counterparts.

 

This
Agreement may be executed in multiple counterparts, each of which shall be deemed an original, but both of which together shall
constitute one and the same instrument.

 

13.
Section Headings.

 

The
Section headings contained in this Agreement are for reference purposes only and shall not affect in anyway the meaning or interpretation
of this Agreement.

 

14.
Public Disclosure.

 

A
copy of this agreement will be formally filed by Argentum 47, Inc. with the U.S. Securities and Exchange Commission (“SEC”),
via a Form 8-K Current Report within three business days from the date of execution hereof.

 

    	 

    	 

    

 

IN
WITNESS WHEREOF, the Parties hereto have executed this Agreement as of the day first written above.

 

Xantis
S.A., for and on behalf of Keyholder Three Securistation Fund (to be renamed Aegeus Securitisation Fund).

 

	/s/
    Janice Allgrove	 
	Mr.
    Janice Allgrove - Director	 
	 	 
	/s/
    Eva Fridrich	 
	Miss
    Eva Fridrich - Director	 
	 	 
	Argentum
    47, Inc.	 
	 	 
	/s/
    Enzo Taddei	 
	Mr.
    Enzo Taddei – Director	 
	 	 
	/s/
    Peter Smith	 
	Mr.
    Peter Smith – Director

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00302-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00302-of-00352.parquet"}]]